SCHEMBL4128765

SCHEMBL4128765

Cn1c(=O)[nH]c2ccc(CN3CCC(CC4CC4)(C(=O)NCc4cncc(C(F)(F)F)c4)C3)cc21

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 9/20 0.38
MCHR2 Q969V1 1/20 0.36
GLS O94925 3/20 0.36
CDK2 P24941 1/20 0.35
AKT1 P31749 1/20 0.35
GAA P10253 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KCNH2 Q12809 3/20 0.34
USP2 O75604 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
HIF1A Q16665 1/20 0.34
WNT1 P04628 1/20 0.34
DYRK1A Q13627 1/20 0.34
BRD4 O60885 1/20 0.33
ACKR3 P25106 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3791324 0.92 CCR2 (0.45) CCR2MCHR2KCNH2USP2CYP3A4
SCHEMBL3782902 0.88 KCNH2 (0.39) CCR2MCHR2GLSGAASMN1; SMN2
SCHEMBL3786892 0.86 CCR2 (0.36) CCR2GLSGAASMN1; SMN2KCNH2
SCHEMBL3788446 0.85 GLS (0.42) CCR2MCHR2GLSKCNH2USP2
SCHEMBL3786528 0.85 WNT1 (0.40) CCR2MCHR2GLSKCNH2WNT1
SCHEMBL3781517 0.84 DRD4 (0.46) CCR2
SCHEMBL3785872 0.84 CCR2 (0.38) CCR2GLSGAASMN1; SMN2KCNH2
SCHEMBL3784437 0.84 CCR2 (0.35) CCR2MCHR2GLSGAASMN1; SMN2
SCHEMBL3787852 0.82 CCR2 (0.37) CCR2GLSGAASMN1; SMN2KCNH2
SCHEMBL4139060 0.82 KLKB1 (0.37) CCR2GLSGAASMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009076404-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE CHEMOKINE CCR2 RECEPTOR EPIX DELAWARE, INC. (US) 2009-06-18 WO claimed
WO-2009076404-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE CHEMOKINE CCR2 RECEPTOR EPIX DELAWARE, INC. (US) 2009-06-18 WO disclosed